China's CStone raises $285M in IPO; Axial raises $25M for microbiome work on Parkinson's, autism
→ Targeting the axis between the gut and the brain, microbiome startup Axial has landed a $25 million B round as it looks to advance programs for Parkinson’s disease and autism. Seventure Partners, through its microbiome-focused fund Health for Life Capital, led the round alongside the Longwood Fund, Domain Associates, Heritage Medical Systems and “a group of high net worth individuals based in Southern California.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.